| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,109 |
22,130 |
$2.45M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,946 |
10,434 |
$1.29M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,693 |
2,550 |
$998K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,644 |
4,795 |
$621K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,149 |
3,473 |
$437K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,387 |
3,903 |
$396K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,459 |
1,586 |
$369K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,386 |
1,132 |
$317K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,438 |
1,203 |
$313K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,121 |
3,733 |
$274K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,925 |
1,270 |
$263K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,448 |
1,355 |
$245K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,551 |
2,965 |
$213K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,992 |
1,450 |
$208K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,491 |
791 |
$195K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
749 |
630 |
$177K |
| 80053 |
Comprehensive metabolic panel |
16,928 |
13,532 |
$177K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,154 |
675 |
$166K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,778 |
1,093 |
$146K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
747 |
621 |
$145K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
622 |
548 |
$132K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,162 |
969 |
$126K |
| G0378 |
Hospital observation service, per hour |
1,716 |
644 |
$106K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
535 |
471 |
$91K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
278 |
230 |
$67K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,324 |
18,801 |
$56K |
| 59025 |
Fetal non-stress test |
350 |
148 |
$55K |
| 99215 |
Prolong outpt/office vis |
587 |
473 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
2,470 |
2,226 |
$51K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,092 |
1,021 |
$39K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,713 |
1,573 |
$38K |
| 36415 |
Collection of venous blood by venipuncture |
20,008 |
15,864 |
$38K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
338 |
271 |
$31K |
| 76801 |
|
297 |
223 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,931 |
2,478 |
$31K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,330 |
515 |
$31K |
| 84439 |
|
2,192 |
1,849 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,004 |
937 |
$29K |
| 64493 |
|
89 |
49 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,719 |
3,923 |
$25K |
| 96367 |
|
511 |
354 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,624 |
1,296 |
$25K |
| 80074 |
|
1,523 |
1,404 |
$24K |
| 94060 |
|
216 |
175 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
879 |
779 |
$24K |
| 85027 |
|
2,411 |
2,111 |
$23K |
| 97161 |
|
518 |
437 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,170 |
6,903 |
$23K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,027 |
894 |
$22K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
505 |
439 |
$21K |
| 80061 |
Lipid panel |
1,783 |
1,546 |
$20K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
152 |
88 |
$19K |
| 97113 |
|
256 |
96 |
$18K |
| 74018 |
|
536 |
447 |
$17K |
| 87522 |
Neg quan hep c or qual rna |
516 |
488 |
$17K |
| 84702 |
|
922 |
572 |
$17K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
342 |
303 |
$17K |
| 76830 |
Ultrasound, transvaginal |
490 |
430 |
$16K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
113 |
97 |
$16K |
| 97162 |
|
369 |
336 |
$15K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
74 |
60 |
$14K |
| 86780 |
|
667 |
563 |
$14K |
| 72100 |
|
440 |
380 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,327 |
1,139 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
879 |
779 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,082 |
1,753 |
$13K |
| 82607 |
|
610 |
533 |
$13K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
211 |
151 |
$12K |
| 82728 |
|
696 |
612 |
$12K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
236 |
78 |
$12K |
| 76770 |
|
103 |
95 |
$12K |
| 64635 |
|
110 |
49 |
$12K |
| 94729 |
|
223 |
185 |
$12K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
773 |
684 |
$12K |
| 86850 |
|
581 |
462 |
$11K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
557 |
492 |
$11K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
16 |
13 |
$10K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
78 |
76 |
$9K |
| 97535 |
Self-care/home management training, each 15 minutes |
305 |
189 |
$9K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
12 |
$9K |
| 94726 |
|
163 |
129 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
68 |
62 |
$9K |
| 73562 |
|
512 |
408 |
$8K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
69 |
56 |
$8K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
42 |
38 |
$8K |
| 83655 |
|
351 |
317 |
$8K |
| 83540 |
|
741 |
658 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
137 |
115 |
$7K |
| 86140 |
|
1,159 |
988 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
448 |
391 |
$7K |
| 83735 |
|
5,537 |
3,966 |
$7K |
| 71250 |
|
124 |
115 |
$7K |
| 80076 |
|
952 |
781 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
364 |
304 |
$6K |
| 86900 |
|
622 |
489 |
$6K |
| 73030 |
|
407 |
335 |
$6K |
| 0012A |
|
153 |
147 |
$6K |
| 73630 |
|
465 |
384 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
505 |
439 |
$5K |
| 84484 |
|
4,298 |
3,391 |
$5K |
| 97166 |
|
76 |
67 |
$5K |
| 0011A |
|
152 |
137 |
$5K |
| 83550 |
|
637 |
563 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
3,320 |
2,776 |
$5K |
| 82570 |
|
732 |
593 |
$5K |
| 73130 |
|
398 |
331 |
$4K |
| 73610 |
|
405 |
325 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,745 |
3,818 |
$4K |
| 83970 |
|
150 |
126 |
$4K |
| 81001 |
|
1,140 |
926 |
$4K |
| 93017 |
|
64 |
53 |
$4K |
| 86901 |
|
622 |
489 |
$4K |
| 85610 |
|
3,932 |
2,621 |
$4K |
| 97010 |
|
103 |
40 |
$4K |
| 81003 |
|
10,066 |
8,838 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,972 |
3,103 |
$4K |
| 73502 |
|
186 |
173 |
$3K |
| 85652 |
|
555 |
487 |
$3K |
| 81514 |
|
14 |
14 |
$2K |
| 82746 |
|
189 |
158 |
$2K |
| 93975 |
|
24 |
13 |
$2K |
| 73110 |
|
161 |
146 |
$2K |
| 85018 |
|
374 |
280 |
$2K |
| 82950 |
|
149 |
132 |
$2K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
12 |
12 |
$2K |
| 86787 |
|
52 |
39 |
$2K |
| 90715 |
|
121 |
100 |
$2K |
| 87077 |
|
795 |
663 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
642 |
598 |
$1K |
| 87660 |
|
79 |
79 |
$1K |
| 84100 |
|
478 |
364 |
$1K |
| 92523 |
|
17 |
12 |
$1K |
| 86803 |
|
67 |
54 |
$1K |
| 84550 |
|
303 |
238 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,668 |
2,601 |
$1K |
| 83690 |
|
2,510 |
1,989 |
$1K |
| 84146 |
|
70 |
58 |
$1K |
| 84153 |
|
92 |
80 |
$1K |
| 82043 |
|
201 |
171 |
$1K |
| 96376 |
|
1,084 |
638 |
$1K |
| 86762 |
|
61 |
43 |
$1K |
| 84156 |
|
350 |
252 |
$1K |
| 83880 |
|
1,103 |
892 |
$1K |
| 86038 |
|
38 |
24 |
$879.91 |
| 27096 |
|
20 |
14 |
$876.67 |
| 87186 |
|
442 |
372 |
$870.58 |
| 85730 |
|
1,286 |
1,072 |
$821.98 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,440 |
2,893 |
$753.95 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,185 |
1,044 |
$750.70 |
| 82077 |
|
1,127 |
889 |
$742.19 |
| 83001 |
|
31 |
29 |
$676.73 |
| 64494 |
|
94 |
49 |
$670.76 |
| 87480 |
|
37 |
37 |
$656.51 |
| 81025 |
|
3,581 |
2,953 |
$645.02 |
| 82550 |
|
181 |
129 |
$614.40 |
| 87040 |
|
523 |
431 |
$593.63 |
| 82784 |
|
30 |
26 |
$456.30 |
| 85379 |
|
1,260 |
1,054 |
$418.40 |
| 82565 |
|
63 |
53 |
$381.67 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
17 |
$362.34 |
| 80143 |
|
551 |
447 |
$346.84 |
| 0031A |
|
12 |
12 |
$342.62 |
| 87510 |
|
37 |
37 |
$337.12 |
| 36591 |
|
23 |
12 |
$335.69 |
| 73080 |
|
25 |
24 |
$280.44 |
| 83605 |
|
1,370 |
1,072 |
$270.14 |
| 87340 |
|
12 |
12 |
$266.04 |
| 94664 |
|
253 |
168 |
$234.66 |
| 83002 |
|
13 |
13 |
$214.62 |
| 84481 |
|
14 |
14 |
$214.42 |
| 73590 |
|
15 |
12 |
$194.81 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
557 |
539 |
$192.98 |
| 84403 |
|
14 |
13 |
$183.22 |
| 97163 |
|
14 |
12 |
$164.09 |
| 80179 |
|
520 |
421 |
$163.05 |
| 85014 |
|
57 |
25 |
$136.72 |
| 82140 |
|
31 |
13 |
$132.19 |
| 82803 |
|
262 |
195 |
$130.77 |
| 83615 |
|
41 |
28 |
$118.56 |
| 82248 |
|
17 |
15 |
$108.78 |
| 84703 |
|
29 |
26 |
$80.38 |
| 82010 |
|
23 |
15 |
$65.70 |
| 84145 |
|
138 |
110 |
$65.32 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
77 |
73 |
$46.16 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
40 |
36 |
$43.84 |
| 84132 |
|
48 |
32 |
$41.65 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
392 |
272 |
$38.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,119 |
902 |
$38.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
206 |
115 |
$37.63 |
| 82272 |
|
16 |
12 |
$31.96 |
| J7050 |
Infusion, normal saline solution, 250 cc |
767 |
381 |
$25.93 |
| 82150 |
|
42 |
40 |
$22.83 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
38 |
28 |
$21.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
688 |
546 |
$20.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
16 |
$19.96 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
492 |
414 |
$19.46 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
702 |
443 |
$17.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
305 |
222 |
$16.36 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
171 |
68 |
$16.03 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
35 |
25 |
$14.05 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
267 |
220 |
$12.96 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,141 |
825 |
$12.21 |
| 94760 |
|
237 |
207 |
$10.02 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
33 |
25 |
$10.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
36 |
26 |
$7.88 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
901 |
558 |
$7.03 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
120 |
90 |
$4.80 |
| 91301 |
|
322 |
295 |
$3.15 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
98 |
93 |
$2.52 |
| J2704 |
Injection, propofol, 10 mg |
874 |
713 |
$1.80 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
388 |
330 |
$0.26 |
| 91303 |
|
12 |
12 |
$0.10 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
315 |
215 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
17 |
12 |
$0.00 |
| 51702 |
|
12 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
125 |
95 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
355 |
309 |
$0.00 |
| A9270 |
Non-covered item or service |
242 |
195 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
46 |
37 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
64 |
41 |
$0.00 |
| 87807 |
|
28 |
28 |
$0.00 |
| 80320 |
|
12 |
12 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$0.00 |